Aceso Life Science Group Enters Non-Binding Term Sheet for Refinancing 2018 Facility Agreement

Reuters

07/14

Aceso Life Science Group Enters Non-Binding Term Sheet for Refinancing 2018 Facility Agreement

Aceso Life Science Group Ltd. has announced a voluntary update regarding a potential refinancing arrangement for its existing facility agreement dated 9 March 2018. The company has entered into a non-legally binding term sheet with the facility and security agent, aiming to refinance the outstanding amount under the 2018 Facility Agreement. This possible facility will be used not only to address the existing debt but also to fund additional capital investments in the company's commercial properties located at 55 Mark Lane, London. The parties involved are working towards finalizing a legally-binding agreement by August 2025. Aceso Life Science Group emphasized that the outcome of this arrangement remains uncertain and advised shareholders and investors to exercise caution. Further announcements will be made as developments occur.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Aceso Life Science Group Ltd. published the original content used to generate this news brief on July 14, 2025, and is solely responsible for the information contained therein.

免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。

熱議股票

1
2
3
4
5
6
7
8
9
10

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/news/2551218977"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2551218977\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/2551218977?lang=zh_TW&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-07-14 20:55","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2551218977","market":"fut","top_or_hot":-1,"title":"Aceso Life Science Group Enters Non-Binding Term Sheet for Refinancing 2018 Facility Agreement","media":"Reuters","content":"<html xmlns=\"http://www.w3.org/1999/xhtml\" xmlns:newsg2=\"http://iptc.org/std/nar/2006-10-01/\" xmlns:xhtml=\"http://www.w3.org/1999/xhtml\"><head><title>\n      Aceso Life Science Group Enters Non-Binding Term Sheet for Refinancing 2018 Facility Agreement\n    </title></head><body><div xmlns:xsd=\"http://www.w3.org/2001/XMLSchema\" xmlns:xsi=\"http://www.w3.org/2001/XMLSchema-instance\">\n<p>\n        Aceso Life Science Group Ltd. has announced a voluntary update regarding a potential refinancing arrangement for its existing facility agreement dated 9 March 2018. The company has entered into a non-legally binding term sheet with the facility and security agent, aiming to refinance the outstanding amount under the 2018 Facility Agreement. This possible facility will be used not only to address the existing debt but also to fund additional capital investments in the company's commercial properties located at 55 Mark Lane, London. The parties involved are working towards finalizing a legally-binding agreement by August 2025. Aceso Life Science Group emphasized that the outcome of this arrangement remains uncertain and advised shareholders and investors to exercise caution. Further announcements will be made as developments occur.\n      </p>\n</div><div xmlns:xsd=\"http://www.w3.org/2001/XMLSchema\" xmlns:xsi=\"http://www.w3.org/2001/XMLSchema-instance\">\n<em>Disclaimer: <span>This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Aceso Life Science Group Ltd. published the original content used to generate this news brief on July 14, 2025, and is solely responsible for the information contained therein.</span></em>\n</div></body></html>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Aceso Life Science Group Enters Non-Binding Term Sheet for Refinancing 2018 Facility Agreement</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nAceso Life Science Group Enters Non-Binding Term Sheet for Refinancing 2018 Facility Agreement\n</h2>\n<h4 class=\"meta\">\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1032215980\">\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time smaller\">2025-07-14 20:55</p>\n</div>\n</a>\n</h4>\n</header>\n<article>\n<html xmlns=\"http://www.w3.org/1999/xhtml\" xmlns:newsg2=\"http://iptc.org/std/nar/2006-10-01/\" xmlns:xhtml=\"http://www.w3.org/1999/xhtml\"><head><title>\n      Aceso Life Science Group Enters Non-Binding Term Sheet for Refinancing 2018 Facility Agreement\n    </title></head><body><div xmlns:xsd=\"http://www.w3.org/2001/XMLSchema\" xmlns:xsi=\"http://www.w3.org/2001/XMLSchema-instance\">\n<p>\n        Aceso Life Science Group Ltd. has announced a voluntary update regarding a potential refinancing arrangement for its existing facility agreement dated 9 March 2018. The company has entered into a non-legally binding term sheet with the facility and security agent, aiming to refinance the outstanding amount under the 2018 Facility Agreement. This possible facility will be used not only to address the existing debt but also to fund additional capital investments in the company's commercial properties located at 55 Mark Lane, London. The parties involved are working towards finalizing a legally-binding agreement by August 2025. Aceso Life Science Group emphasized that the outcome of this arrangement remains uncertain and advised shareholders and investors to exercise caution. Further announcements will be made as developments occur.\n      </p>\n</div><div xmlns:xsd=\"http://www.w3.org/2001/XMLSchema\" xmlns:xsi=\"http://www.w3.org/2001/XMLSchema-instance\">\n<em>Disclaimer: <span>This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Aceso Life Science Group Ltd. published the original content used to generate this news brief on July 14, 2025, and is solely responsible for the information contained therein.</span></em>\n</div></body></html>\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK1188","symbol_name":"消費信貸","start_time":0,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250714:nNDL4c3Bb7:1","article_id":"2551218977","we_media_id":"1032215980","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2551218977","pubTimestamp":1752497728,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Reuters","introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"id":"1032215980","head_image":"https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48"},"summary":"Aceso Life Science Group Ltd. has announced a voluntary update regarding a potential refinancing arrangement for its existing facility agreement dated 9 March 2018. The company has entered into a non-legally binding term sheet with the facility and security agent, aiming to refinance the outstanding amount under the 2018 Facility Agreement. This possible facility will be used not only to address the existing debt but also to fund additional capital investments in the company's commercial properties located at 55 Mark Lane, London. The parties involved are working towards finalizing a legally-binding agreement by August 2025. Aceso Life Science Group emphasized that the outcome of this arrangement remains uncertain and advised shareholders and investors to exercise caution. Further announcements will be made as developments occur.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely inf","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"BK1188":"消费信贷","00474":"信铭生命科技"},"translate_title":"Aceso Life Science Group签订2018年再融资融资协议的非约束性条款清单","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"00474":0.9},"content_text":"Aceso Life Science Group Enters Non-Binding Term Sheet for Refinancing 2018 Facility Agreement\n    \n\n        Aceso Life Science Group Ltd. has announced a voluntary update regarding a potential refinancing arrangement for its existing facility agreement dated 9 March 2018. The company has entered into a non-legally binding term sheet with the facility and security agent, aiming to refinance the outstanding amount under the 2018 Facility Agreement. This possible facility will be used not only to address the existing debt but also to fund additional capital investments in the company's commercial properties located at 55 Mark Lane, London. The parties involved are working towards finalizing a legally-binding agreement by August 2025. Aceso Life Science Group emphasized that the outcome of this arrangement remains uncertain and advised shareholders and investors to exercise caution. Further announcements will be made as developments occur.\n      \n\nDisclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Aceso Life Science Group Ltd. published the original content used to generate this news brief on July 14, 2025, and is solely responsible for the information contained therein.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"}}}